Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist being developed for metabolic research. This white powder formulation shows high purity (99%) and is supplied in vacuum-sealed vials for research use only.
The compound demonstrates significant potential in glucose control and weight management studies, showing superior efficacy compared to selective GLP-1 receptor agonists. Researchers interested in where to buy tirzepatide for academic or pharmaceutical development can source this high-quality material through our manufacturing network.
Key features of our tirzepatide include complete removal of trifluoroacetic acid (TFA) residues, ensuring research safety. The material is stable when stored properly and can be customized in various packaging configurations to meet specific study requirements.
For those researching metabolic pathways, tirzepatide offers multiple mechanisms of action including slowing gastric emptying, reducing liver glucose production, and enhancing pancreatic insulin secretion in hyperglycemic conditions.
Our production capabilities allow for bulk quantities with consistent quality, making us a reliable source for researchers looking where to buy tirzepatide in larger volumes. Each batch undergoes rigorous quality control to ensure pharmaceutical-grade purity and performance.